Pawal Kawalec

Learn More
AIMS This study assessed the cost efficacy and cost utility of the automatic blood glucose meter CONTOUR(®) TS from the public payer (National Health Fund [NHF]) and payer (patient and NHF) perspectives over a 26-year analysis horizon. METHODS Clinical effectiveness data were obtained from prior clinical studies of automatic versus manually coded blood(More)